United Therapeutics, Liquidia settle Yutrepia patent litigation, agree to dismiss cases with prejudice
Bitget2026/10/14 11:04- United Therapeutics reached a settlement with Liquidia to end multiple patent disputes tied to Yutrepia sales and labeling.
- Liquidia must pay USD 185 million within 30 business days for past PH-ILD sales from June 2, 2025 through execution.
- Liquidia also agreed to pay USD 145.4 million in two installments due by Jan. 31, 2027 and Apr. 30, 2027.
- United Therapeutics will pay Liquidia USD 10 million to resolve a separate New Jersey case involving Sandoz and RareGen.
- Claims against former Liquidia executive Robert Roscigno, as an individual, remain pending and were excluded from the releases.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.

Why Nintendo Stock Is One to Watch Ahead of the Holiday Season

A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.

Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.